The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Immunotherapy in cervical cancer: an innovative approach for better treatment outcomes”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2025 |
Ammar AlAbdullatif, Sarah Almofty, Gazali Tanimu, Hatim Dafalla, Fatimah Alahmari, B. Rabindran Jermy. Tribulus terrestris-Mediated ZnO/Ag-Halloysite Nanohybrids for Targeted Cisplatin and Carboplatin Delivery in Cervical Cancer Treatment, Pharmaceuticals. 2025; 18: 1349. https://doi.org/10.3390/ph18091349 |
|
2 |
2025 |
Rashidul Alam Mahumud, Optimising Cancer Medicine in Clinical Practices: Are Neoadjuvant and Adjuvant Immunotherapies Affordable for Cancer Patients in Low- and Middle-Income Countries?, Cancers. 2025; 17: 1722. https://doi.org/10.3390/cancers17101722 |
|
3 |
2025 |
Emmanuel Ifeanyi Obeagu, Anemia and hematocrit decline in cervical cancer: unveiling clinical consequences and management strategies, Annals of Medicine & Surgery. 2025; 87: 5784. https://doi.org/10.1097/MS9.0000000000003620 |
|
4 |
2025 |
Deo Rei L. Agnila, Rahul Jain, Michael J. Diaz, Tabitha R. Hudlock, Rachel A. Eakins, Andrea Chobrutskiy, Boris I. Chobrutskiy, George Blanck. TCR CDR3 chemical complementarity to HPV epitopes is associated with a better outcome for cervical cancer, Mammalian Genome. 2025; 36: 683. https://doi.org/10.1007/s00335-025-10127-x |
|
5 |
2025 |
Maria Eduarda Palomba, Julia Adriana Karmirski, Flávio Carneiro Hojaij. Efficacy of Neoadjuvant Cemiplimab Treatment for Cutaneous Squamous Cell Carcinoma—A Systematic Review, International Journal of Molecular Sciences. 2025; 26: 8109. https://doi.org/10.3390/ijms26168109 |